A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.
Explore how HPV tumours are targeted by innovative vaccine designs that enhance immune response against cancer effectively.
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results